Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Big Easy Weight Loss vs Boston Medical Group

Big Easy Weight Loss
Graded #56

Higher grade

vs+13.399999999999999
Boston Medical Group
Graded #279

Lower grade

The verdict

Big Easy Weight Loss takes it — 75.3/100 to 61.9/100.

Big Easy Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Big Easy Weight Loss (joinbigeasy.com) is a New Orleans MD-run telehealth that ships compounded GLP-1 medication nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBig Easy Weight Loss +35
89
54
Dose & formulationBig Easy Weight Loss +20
72
52
Clinical oversightBoston Medical Group +11
78
89
Labs & monitoringBoston Medical Group +1
52
53
FulfillmentBig Easy Weight Loss +25
90
65
Contract termsEven
55
55
Big Easy Weight Loss · left barBoston Medical Group · right bar

The numbers

MetricBig Easy Weight LossBoston Medical Group
WeighScore75.3/10061.9/100
GradeCC
Scorecard rank#56#279
Semaglutide$133/mo (all doses, compounded)$199/mo (starting strength, rising with dose, compounded)
Tirzepatide$166/mo (all doses, compounded)Not disclosed
CoverageAll 50 states7 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Big Easy Weight Loss

Graded #56 · C

Strengths

  • Low pricing: about 133 dollars per month for semaglutide, 166 for tirzepatide
  • Site states it serves all 50 states with a 2 to 3 day pharmacy turnaround
  • Names its partner compounding pharmacies and a Chief Medical Officer

Where it loses points

  • Priced as 10 to 12-week packages rather than a simple monthly fee
  • New-patient pricing is promotional and may rise on renewal
Boston Medical Group

Graded #279 · C

Strengths

  • An established medical group with a defined 12-week programme rather than an open-ended subscription
  • The price range and the 12-week total are both published, once you reach the costs page
  • Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight

Where it loses points

  • The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
  • The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
  • The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
  • Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard